У нас вы можете посмотреть бесплатно Ultrasound Guided Foam Sclerotherapy & Blood Clots: The Truth About DVT Risk; Facts versus Fiction или скачать в максимальном доступном качестве, видео которое было загружено на ютуб. Для загрузки выберите вариант из формы ниже:
Если кнопки скачивания не
загрузились
НАЖМИТЕ ЗДЕСЬ или обновите страницу
Если возникают проблемы со скачиванием видео, пожалуйста напишите в поддержку по адресу внизу
страницы.
Спасибо за использование сервиса ClipSaver.ru
Groundbreaking research from Professor Kurosh Parsi and colleagues addresses this important question. Let’s review this paper and at the end, I’ll give you my views on the implications for practising UGFS. The key takeaway from Parsi's research is the distinction between deep vein sclerosis (DVS) and deep vein thrombosis (DVT). The paper states that in a 6-year period, 251 cases of DVS were identified. This represents 2.74% of the 9,143 procedures performed. In the study, Deep Vein Thrombosis (DVT) occurred in 7 out of 9,143 procedures, which translates to an incidence rate of 0.07%. That’s a tiny fraction, the risk of DVT is very low! DVS, a non-thrombotic, fibrotic occlusion, is far more common than DVT following sclerotherapy. In fact, their study found that only a tiny fraction of deep vein occlusions (DVOs) were actual DVTs. The paper identifies the following risk factors for DVT: Higher foam volumes: There was a statistically significant relationship between the risk of DVT and higher foam volumes (p=0.0276). The mean foam volume for DVT was 13.4 mL (6-25 mL) vs. 8.5 mL (1-21 mL) for controls. No significant relationship was found between the risk of DVT and: Foam concentration (p=.9999) Gender Thrombophilia The side of the treated leg (right vs. left) This is a game-changer for our understanding of sclerotherapy's safety profile. Time Stamps: 00:00 Ultrasound Guided Foam Sclerotherapy & Blood Clots: The Truth About DVT Risk; Facts versus Fiction 00:35 Ground Breaking Research: Deep Vein Sclerosis 01:10 Deep Vein Sclerosis vs Deep Vein Thrombosis 02:00 True Incidence of DVT after Foam Sclerotherapy 02:53 Clinical Significance of Deep Vein Occlusion after Foam Sclerotherapy 04:20 Role of D-Dimer in Deep Vein Occlusion after Foam Sclerotherapy Key Findings for Vein Specialists: The significance of DVS lies in its potential to change the way Deep Vein Occlusions (DVO) are managed after sclerotherapy. DVS is a distinct, less harmful condition: DVS is a non-thrombotic, fibrotic occlusion, different from the more dangerous fibrin-based clot of DVT. This distinction is crucial as DVS is less likely to cause serious complications like pulmonary embolism. DVS does not require anticoagulation: Most DVS cases resolve on their own without the need for blood thinners, unlike DVT, which necessitates anticoagulation. This can reduce the risk of bleeding complications and unnecessary treatment for patients. DVS is often followed by vein recovery: The affected veins in DVS often regain patency and competence over time, meaning they can function normally again. This is a positive outcome for patients, as it preserves their venous health. Therefore, recognizing and correctly diagnosing DVS can prevent unnecessary anticoagulation and patient anxiety, leading to more appropriate and effective treatment for DVOs following sclerotherapy.D-dimer as a diagnostic tool: D-dimer levels can help differentiate between DVS and DVT, allowing for more targeted patient management. Implications for Practice: These findings have significant implications for our sclerotherapy practices. By recognizing that DVS is the more common and less worrisome outcome, we can avoid unnecessary anticoagulation and patient anxiety. Additionally, we can refine our techniques to minimise the risk of both DVS and DVT. I recommend reading professor parsi’s paper in full. It has some wonderful ultrasound images of the distinction between DVS and DVT. Check out the links below and consider subscribing so you don’t miss my next video. Professor Kurosh Parsi's publication https://journals.sagepub.com/doi/10.1... Let's connect on LinkedIn / dr-haroun-gajraj Acknowledgement I am grateful to Dr Chris Pittman for bringing this important paper to my attention / christopherpittmanmd My interview with Professor Bruce Campbell • Cyanoacrylate Venous Closure - Super Glue ... Disclaimer: This video is for educational purposes only and should not be considered a substitute for professional medical advice. Always consult with a qualified healthcare provider regarding any questions or concerns about your health. Thank you for joining me today. Please like, share, and subscribe for more informative content on vein health and treatment. 👉 Check out these links 🔗 https://www.veincare.academy/bas-2025... 🔗 https://www.veincare.academy/ 🔗 https://www.veincare.academy/freebies 🔗 https://www.veincare.academy/blog 🔗 https://www.veincare.academy/subscrib... 🔗 https://www.veincare.academy/bas-2024... 🔗 https://www.veincare.academy/bas-2025... 🔗 https://www.veincare.academy/free-gui... 🔗 https://www.veincare.academy/free-gui...